You are here

Abattis Bioceuticals Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
ATT
CSE Index: 
Currency: 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis follows strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.

You are here

Abattis Bioceuticals Corp. (ATT)

SEDAR Information

Abattis Bioceuticals Corp.
Date: September 18, 2017
Abattis Bioceuticals Corp.
Date: September 13, 2017
Abattis Bioceuticals Corp.
Date: August 28, 2017
Abattis Bioceuticals Corp.
Date: August 23, 2017
Abattis Bioceuticals Corp.
Date: August 21, 2017
Abattis Bioceuticals Corp.
Date: August 15, 2017
Abattis Bioceuticals Corp.
Date: August 11, 2017
Abattis Bioceuticals Corp.
Date: August 11, 2017
Abattis Bioceuticals Corp.
Date: August 9, 2017
Abattis Bioceuticals Corp.
Date: July 25, 2017
Abattis Bioceuticals Corp.
Date: July 17, 2017
Abattis Bioceuticals Corp.
Date: July 13, 2017
Abattis Bioceuticals Corp.
Date: July 7, 2017
Abattis Bioceuticals Corp.
Date: July 7, 2017
Abattis Bioceuticals Corp.
Date: June 14, 2017
Abattis Bioceuticals Corp.
Date: May 10, 2017
Abattis Bioceuticals Corp.
Date: May 3, 2017
Abattis Bioceuticals Corp.
Date: April 26, 2017
Abattis Bioceuticals Corp.
Date: April 10, 2017
Abattis Bioceuticals Corp.
Date: April 6, 2017
Abattis Bioceuticals Corp.
Date: March 20, 2017
Abattis Bioceuticals Corp.
Date: March 13, 2017
Abattis Bioceuticals Corp.
Date: March 13, 2017
Abattis Bioceuticals Corp.
Date: February 15, 2017
Abattis Bioceuticals Corp.
Date: February 6, 2017
Abattis Bioceuticals Corp.
Date: February 2, 2017
Abattis Bioceuticals Corp.
Date: January 16, 2017
Abattis Bioceuticals Corp.
Date: December 19, 2016
Abattis Bioceuticals Corp.
Date: December 16, 2016
Abattis Bioceuticals Corp.
Date: December 9, 2016
Abattis Bioceuticals Corp.
Date: November 21, 2016
Abattis Bioceuticals Corp.
Date: November 14, 2016
Abattis Bioceuticals Corp.
Date: November 9, 2016
Abattis Bioceuticals Corp.
Date: November 7, 2016
Abattis Bioceuticals Corp.
Date: November 2, 2016
Abattis Bioceuticals Corp.
Date: October 24, 2016
Abattis Bioceuticals Corp.
Date: October 21, 2016
Abattis Bioceuticals Corp.
Date: October 17, 2016
Abattis Bioceuticals Corp.
Date: October 5, 2016
Abattis Bioceuticals Corp.
Date: October 3, 2016
Abattis Bioceuticals Corp.
Date: September 27, 2016
Abattis Bioceuticals Corp.
Date: September 22, 2016
Abattis Bioceuticals Corp.
Date: September 12, 2016
Abattis Bioceuticals Corp.
Date: August 12, 2016
Abattis Bioceuticals Corp.
Date: August 10, 2016
Abattis Bioceuticals Corp.
Date: July 8, 2016
Abattis Bioceuticals Corp.
Date: June 3, 2016
Abattis Bioceuticals Corp.
Date: May 26, 2016
Abattis Bioceuticals Corp.
Date: May 11, 2016
Abattis Bioceuticals Corp.
Date: April 25, 2016
Abattis Bioceuticals Corp.
Date: April 18, 2016
Abattis Bioceuticals Corp.
Date: April 18, 2016
Abattis Bioceuticals Corp.
Date: April 12, 2016
Abattis Bioceuticals Corp.
Date: April 6, 2016
Abattis Bioceuticals Corp.
Date: March 3, 2016
Abattis Bioceuticals Corp.
Date: February 10, 2016
Abattis Bioceuticals Corp.
Date: December 3, 2015
Abattis Bioceuticals Corp.
Date: November 16, 2015
Abattis Bioceuticals Corp.
Date: November 5, 2015
Abattis Bioceuticals Corp.
Date: October 6, 2015
Abattis Bioceuticals Corp.
Date: September 17, 2015
Abattis Bioceuticals Corp.
Date: September 4, 2015
Abattis Bioceuticals Corp.
Date: August 24, 2015
Abattis Bioceuticals Corp.
Date: August 21, 2015
Abattis Bioceuticals Corp.
Date: August 20, 2015
Abattis Bioceuticals Corp.
Date: August 14, 2015
Abattis Bioceuticals Corp.
Date: July 23, 2015
Abattis Bioceuticals Corp.
Date: June 22, 2015
Abattis Bioceuticals Corp.
Date: June 17, 2015
Abattis Bioceuticals Corp.
Date: May 11, 2015
Abattis Bioceuticals Corp.
Date: May 6, 2015
Abattis Bioceuticals Corp.
Date: May 1, 2015
Abattis Bioceuticals Corp.
Date: April 28, 2015
Abattis Bioceuticals Corp.
Date: April 20, 2015
Abattis Bioceuticals Corp.
Date: April 10, 2015
Abattis Bioceuticals Corp.
Date: March 25, 2015
Abattis Bioceuticals Corp.
Date: March 19, 2015
Abattis Bioceuticals Corp.
Date: March 16, 2015
Abattis Bioceuticals Corp.
Date: March 9, 2015
Abattis Bioceuticals Corp.
Date: February 17, 2015
Abattis Bioceuticals Corp.
Date: February 10, 2015
Abattis Bioceuticals Corp.
Date: February 10, 2015
Abattis Bioceuticals Corp.
Date: February 4, 2015
Abattis Bioceuticals Corp.
Date: February 4, 2015
Abattis Bioceuticals Corp.
Date: February 4, 2015
Abattis Bioceuticals Corp.
Date: February 3, 2015
Abattis Bioceuticals Corp.
Date: January 28, 2015
Abattis Bioceuticals Corp.
Date: January 27, 2015
Abattis Bioceuticals Corp.
Date: January 16, 2015

Company Info

Address
224 – 970 Burrard Street
Vancouver, BC V6Z 2R4
Canada
Phone
604-336-0881
Email
news@abattis.com
Website
http://www.abattis.com
Listing date
Thursday, December 23, 2010
Transfer Agent
Computershare Investor Services Inc.
Auditor
DALE MATHESON CARR-HILTON LABONTE LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
162698887
Reserved for Issuance: 
0

Bulletins

03/03/2017

2017-0301 - Reinstatement - Abattis Bioceuticals Corp. (ATT)

March 3, 2017

Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.

The Company has rectified the default situation that gave rise to the suspension.

Effective Date: March 3, 2017

Symbol:  ATT

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com